cjc w ipamorelin what is 1295 with cjc-1295 ipamorelin peptide benefits CJC‑1295 & Ipamorelin Therapy CJC-1295/Ipamorelin – C2 Peptides

The results were consistent: Trunk fat reduction: Tesamorelin-treated patients showed statistically significant reductions in trunk fat versus placebo at 26 weeks.[1] VAT reduction: Using cross-sectional CT imaging, tesamorelin produced approximately 1520% reductions in visceral adipose tissue compared to placebo.[1,2] Triglyceride improvement: Alongside fat reduction, tesamorelin improved triglyceride levels a key marker in metabolic syndrome.[2] Tesamorelin IGF-1 elevation: Treatment reliably elevated IGF-1 levels toward age-appropriate norms, confirming successful GH-axis stimulation.[1] These reductions occurred without dietary caloric restriction being mandated

Schuh Ecotoxicology and Environmental Safety.2021

However, this concept is still in its infancy

however higher hepcidin levels are registered in this population, making low serum iron not only dilutional or nutritional, but linking it to chronic systemic low grade inflammation (Tussing-Humphreys et al., 2010)